Investment Analysts’ upgrades for Wednesday, May 11th:
adidas (OTCMKTS:ADDYY) was upgraded by analysts at Evercore ISI to an outperform rating.
Ashtead Group (LON:AHT) was upgraded by analysts at Royal Bank of Canada to an outperform rating. They currently have GBX 4,625 ($57.02) target price on the stock, down from their previous target price of GBX 4,950 ($61.03).
Arcturus Therapeutics (NASDAQ:ARCT) was upgraded by analysts at Robert W. Baird from an underperform rating to a neutral rating. Robert W. Baird currently has $18.00 target price on the stock, down from their previous target price of $21.00.
Artesian Resources (NASDAQ:ARTNA) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.
Arrowhead Pharmaceuticals (NASDAQ:ARWR) was upgraded by analysts at Robert W. Baird from a neutral rating to an outperform rating. Robert W. Baird currently has $60.00 target price on the stock, down from their previous target price of $71.00.
Ashtead Group (OTCMKTS:ASHTY) was upgraded by analysts at Royal Bank of Canada from a sector perform rating to an outperform rating.
AZEK (NYSE:AZEK) was upgraded by analysts at Zelman & Associates from a hold rating to a buy rating.
Banca Mediolanum (OTCMKTS:BNCDY) was upgraded by analysts at Keefe, Bruyette & Woods from a market perform rating to an outperform rating.
Celsius (NASDAQ:CELH) was upgraded by analysts at Maxim Group from a hold rating to a buy rating. The firm currently has $70.00 price target on the stock.
Core Laboratories (NYSE:CLB) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.
Cummins (NYSE:CMI) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.
Cronos Group (NASDAQ:CRON) was upgraded by analysts at CIBC from a neutral rating to a sector outperform rating.
Cronos Group (NASDAQ:CRON) was upgraded by analysts at Canaccord Genuity Group Inc. from a sell rating to a hold rating. The firm currently has C$4.50 price target on the stock.
Cronos Group (TSE:CRON) was upgraded by analysts at CIBC to a buy rating.
Cronos Group (TSE:CRON) was upgraded by analysts at Canaccord Genuity Group Inc. to a hold rating. The firm currently has C$4.50 target price on the stock.
HF Sinclair (NYSE:DINO) was upgraded by analysts at Cowen Inc from a market perform rating to an outperform rating.
HF Sinclair (NYSE:DINO) was upgraded by analysts at Cowen Inc. from a market perform rating to an outperform rating. The firm currently has $52.00 target price on the stock, up from their previous target price of $38.00.
Electronic Arts (NASDAQ:EA) was upgraded by analysts at Moffett Nathanson from a neutral rating to a buy rating. They currently have $141.00 price target on the stock, down from their previous price target of $151.00.
8X8 (NYSE:EGHT) was upgraded by analysts at B. Riley from a neutral rating to a buy rating. The firm currently has $13.50 target price on the stock.
Exchange Income (TSE:EIF) was upgraded by analysts at Scotiabank to a buy rating. The firm currently has C$56.00 target price on the stock.
Exchange Income (OTCMKTS:EIFZF) was upgraded by analysts at Scotiabank from a sector perform rating to an outperform rating. Scotiabank currently has $56.00 target price on the stock.
Equitable (NYSE:EQH) was upgraded by analysts at UBS Group AG to a positive rating.
Essity AB (publ) (OTCMKTS:ETTYF) was upgraded by analysts at Credit Suisse Group AG from a neutral rating to an outperform rating.
Fortum Oyj (OTCMKTS:FOJCY) was upgraded by analysts at UBS Group AG from a neutral rating to a buy rating.
Great Elm Capital (NASDAQ:GECC) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Great Elm Capital Corp. is a diversified investment company. Its business line consists of investment management, financial products and merchant banking. Great Elm Capital Corp. is based in Baltimore, Maryland. “
Geron (NASDAQ:GERN) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic malignancies. The Company currently is conducting two Phase 3 clinical trials: IMerge in lower risk myelodysplastic syndromes and IMpactMF in refractory myelofibrosis. “
Galapagos (NASDAQ:GLPG) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $63.00 target price on the stock. According to Zacks, “Galapagos NV is a biotechnology company. The Company’s operating segment consists of Research and Development and Services. Research and Development segment is engaged in the discovery and development of small molecules. Services segment offers drug discovery products and services. Its products include GLPG0634 for the treatment of rheumatoid arthritis and other inflammatory diseases, GLPG1205/GLPG1690 for treating inflammatory bowel disease, GSK2586184 for the treatment of chronic immuno-inflammatory diseases and GLPG0974, to prevent free fatty acid-induced activation and migration of neutrophils which are in different clinical trial. Galapagos NV is headquartered in Mechelen, Belgium. “
Gemini Therapeutics (NASDAQ:GMTX) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $1.75 price target on the stock. According to Zacks, “Gemini Therapeutics Inc. is a clinical stage precision medicine company. It engages in developing novel therapeutic compounds to treat genetically defined age-related macular degeneration. The company’s lead candidate principally includes GEM103. Its pipeline includes recombinant proteins, gene therapies and monoclonal antibodies. Gemini Therapeutics Inc., formerly known as FS Development Corp., is based in CAMBRIDGE, Mass. “
Grocery Outlet (NASDAQ:GO) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a hold rating to a buy rating. They currently have $40.00 target price on the stock, up from their previous target price of $29.00.
Gold Resource (NYSEAMERICAN:GORO) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Gold Resource Corporation is a mining company focused on production and pursuing development of select, high-grade gold and silver projects that feature low operation costs and produce high returns on capital. The Company has 100% interest in four potential high-grade gold and silver properties in Mexico’s southern state of Oaxaca. The Company has an interest in four properties, the El Aguila property, the Las Margaritas property, the El Rey property and the Solaga property. All of these properties are in the exploration stage and have no probable reserves. The company is based in Denver, Colorado. “
Goldman Sachs BDC (NYSE:GSBD) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $20.00 price target on the stock. According to Zacks, “Goldman Sachs BDC, Inc. is a specialty finance company. The Company invests primarily in telecommunication services, electronic equipment, instruments and components and real estate management and development industries. Goldman Sachs BDC, Inc. is based in NEW YORK, United States. “
Goldman Sachs BDC (NYSE:GSBD) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.
GlaxoSmithKline (NYSE:GSK) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating.
Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. “
Hilton Grand Vacations (NYSE:HGV) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $47.00 price target on the stock. According to Zacks, “Hilton Grand Vacations Company, LLC, a division of Hilton Worldwide, is engaged in hospitality business. It markets and operates vacation ownership resorts. The company also manages and serves club membership programs which include Hilton Grand Vacations Club(R) and The Hilton Club(R). It operates primarily in USA, Indonesia, Italy, Mexico, New Zealand, Portugal, Scotland and Thailand. Hilton Grand Vacations Company, LLC is headquartered in Orlando, Florida. “
Hims & Hers Health (NYSE:HIMS) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. “
High Tide (NASDAQ:HITI) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “High Tide Inc. is a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories. High Tide Inc. is based in CALGARY, AB. “
Hecla Mining (NYSE:HL) was upgraded by analysts at Roth Capital from a neutral rating to a buy rating. The firm currently has $6.25 target price on the stock, down from their previous target price of $6.50.
Hudson Pacific Properties (NYSE:HPP) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Hudson Pacific Properties, Inc. is a full-service, vertically integrated real estate company focused on owning, operating and acquiring office properties and media and entertainment properties in select growth markets primarily in Northern and Southern California. These markets include Los Angeles, Orange County, San Diego, San Francisco, Silicon Valley and the East Bay. The Company is headquartered in Los Angeles, California. “
Heritage Insurance (NYSE:HRTG) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.
Hostelworld Group (OTC:HSWLF) was upgraded by analysts at Peel Hunt to a buy rating.
Icosavax (NASDAQ:ICVX) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Icosavax Inc. is a biopharmaceutical company which focuses on life-threatening respiratory diseases. The company’s virus-like particle platform technology involved in developing vaccines against infectious diseases. Icosavax Inc. is based in SEATTLE. “
Intercorp Financial Services (NYSE:IFS) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $27.00 price target on the stock. According to Zacks, “Intercorp Financial Services Inc. provides financial products and services. The Company’s business segment consists of Bank, Insurance, Real Estate Operations and Others. Intercorp Financial Services Inc. is based in Lima, Peru. “
Ikena Oncology (NASDAQ:IKNA) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $4.75 price target on the stock. According to Zacks, “Ikena Oncology Inc. is focused on developing cancer therapies targeting key signaling pathways which drive the formation and spread of cancer. The company’s product candidates include IK-930, IK-175, IK-412 and IK-007, which are in clinical stage. Ikena Oncology Inc. is based in Boston, United States. “
Immuneering (NASDAQ:IMRX) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $4.75 target price on the stock. According to Zacks, “Immuneering Corporation is a biopharmaceutical company advancing a pipeline of oncology and neuroscience product candidates. The company’s product candidate includes IMM-1-104. Immuneering Corporation is based in CAMBRIDGE, Mass. “
indie Semiconductor (NASDAQ:INDI) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $6.75 target price on the stock. According to Zacks, “indie Semiconductor provides automotive semiconductors and software platforms. It focus on edge sensors for Advanced Driver Assistance Systems including LiDAR, connected car, user experience and electrification applications. indie Semiconductor, formerly known as Thunder Bridge Acquisition II Ltd., is based in Virginia, United States. “
Innergex Renewable Energy (OTCMKTS:INGXF) was upgraded by analysts at TD Securities from a hold rating to a buy rating.
Innoviva (NASDAQ:INVA) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company’s portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California. “
IRIDEX (NASDAQ:IRIX) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market. “
Ituran Location and Control (NASDAQ:ITRN) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Ituran provides location-based services, consisting predominantly of stolen vehicle recovery and tracking services, as well as wireless communications products used in connection with its location-based services and various other applications. Ituran offers mobile asset location, Stolen Vehicle Recovery, management & control services for vehicles, cargo and personal security, and radio frequency identification products for various purposes including automatic meter reading, electronic toll collection and homeland security applications. “
Jefferies Financial Group (NYSE:JEF) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. The firm currently has $37.00 price target on the stock. According to Zacks, “Jefferies Financial Group Inc. is a diversified financial services company. It engaged in investment banking and capital markets, merchant banking and an alternative asset management platform. The company’s financial service businesses are Berkadia which provide commercial mortgage banking, investment sales and servicing; Leucadia Asset Management provide asset management; HomeFed provide a publicly traded real estate company, FXCM provides online foreign exchange trading services and Foursight Capital provide vehicle finance. Jefferies Financial Group Inc. formerly known as Leucadia National Corporation is based in New York, United States. “
Jounce Therapeutics (NASDAQ:JNCE) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It engaged in developing therapies which enable the immune system to attack tumors. The Company’s lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells found in a range of solid tumors. It also developing JTX-4014 for use in future combinations with JTX-2011, as well as for use in combination with other future product candidates. Jounce Therapeutics, Inc. is based in Cambridge, United States. “
Journey Energy (TSE:JOY) was upgraded by analysts at Stifel Nicolaus to a buy rating. They currently have C$7.50 target price on the stock.
Journey Energy (OTCMKTS:JRNGF) was upgraded by analysts at Stifel Nicolaus from a hold rating to a buy rating. They currently have $7.50 price target on the stock.
Keyera (OTCMKTS:KEYUF) was upgraded by analysts at Raymond James from an outperform rating to a strong-buy rating.
KemPharm (NASDAQ:KMPH) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “KemPharm Inc. is a specialty pharmaceutical company which is engaged in the discovery and development of new molecular entity prodrugs. Its product candidates include KP201/APAP, KP511/ER and KP606/ER for the treatment of pain; KP415 for the treatment of attention deficit hyperactivity disorder and KP303 for the treatment of central nervous system disorders, which are in preclinical trail stage. The Company through its LAT platform technology generate prodrug. KemPharm Inc. is based in CORALVILLE, United States. “
KNOT Offshore Partners (NYSE:KNOP) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “KNOT Offshore Partners LP is engaged in owning, acquiring and operating shuttle tankers, designed to transport crude oil and condensates from offshore oil field installations to onshore terminals and refineries. KNOT Offshore Partners LP is based in Aberdeen, the United Kingdom. “
Kopin (NASDAQ:KOPN) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $1.50 target price on the stock. According to Zacks, “Kopin Corporation is a leading developer and provider of innovative wearable technologies and solutions for integration into head-worn computing and display systems to military, industrial and consumer customers. Kopin’s technologies and solutions are available as components providing individual capabilities or as reference systems providing integrated solutions. Kopin has a long history of developing technologies required for wearable computing headsets for the military, consumers, or industry. Kopin has contributed to the development of head-mounted displays for the F-35 Joint Strike Fighter, created the Golden-i, a wearable headset reference design for industry, and collaborated on many wearable products with a range of companies including Vuzix, Motorola Solutions and Recon Instruments. Kopin has developed and commercialized game-changing technologies such as heterojunction bipolar transistors (HBT) which power billions of cellphones, and microdisplays which have brought vivid images. “
Keros Therapeutics (NASDAQ:KROS) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $49.00 target price on the stock. According to Zacks, “Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of novel treatments for hematological and musculoskeletal disorders. The company’s product pipeline consists of KER-050, KER-047and KER-012 which are in clinical stage. Keros Therapeutics, Inc. is based in LEXINGTON, MA. “
Legal & General Group (OTCMKTS:LGGNY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “LEGAL & GENERAL is a leading UK risk, savings and investment group. Legal & General today provides life assurance and other financial protection products, annuities and long-term savings products including ISA’s and pensions. With over £250 billion in funds under management, it is also the largest investor for UK pension funds. Legal & General has over 5.5 million UK customers. Their products are sold through over thirty bank and building society relationships, through Independent Financial Advisers and also directly to customers. Legal & General Assurance Society Limited, their principal operating company, is one of Europe’s top rated life companies for financial strength, with an AA+ rating from Standard & Poor’s and Aa1 from Moody’s. “
Li-Cycle (NYSE:LICY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Li-Cycle Holdings Corp. involved in lithium-ion battery resource recovery and lithium-ion battery recycles principally in North America. Li-Cycle Holdings Corp., formerly known as Peridot Acquisition Corp., is based in TORONTO. “
aTyr Pharma (NASDAQ:LIFE) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $4.00 target price on the stock. According to Zacks, “aTyr Pharma, Inc. is a bio-therapeutics company. The Company is involved in the discovery and development of medicines for severe, rare diseases of physiological modulators. aTyr Pharma, Inc. is a based in SAN DIEGO, United States. “
LumiraDx (NASDAQ:LMDX) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “LumiraDx Limited is a point of care diagnostics company. Its testing solutions are being deployed by governments and leading healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools and workplaces to screen, diagnose, and monitor wellness as well as disease. LumiraDx Limited, formerly known as CA Healthcare Acquisition Corp., is based in BOSTON. “
Laird Superfood (NYSEMKT:LSF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Laird Superfood Inc. provides plant-based superfood products. Laird Superfood Inc. is based in Sisters, United States. “
Main Street Capital (NYSE:MAIN) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $43.00 price target on the stock. According to Zacks, “Main Street Capital Corporation is a specialty investment company providing customized financing solutions to lower middle market companies which operate in diverse industry sectors. Main Street seeks to partner with entrepreneurs, business owners and management teams and generally provides one stop financing alternatives to its portfolio companies. “
Magenta Therapeutics (NASDAQ:MGTA) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $1.25 target price on the stock. According to Zacks, “Magenta Therapeutics Inc. is a clinical-stage biotechnology company. It engaged in developing therapeutics focused on critical areas of unmet need in the field of bone marrow transplant for patients with autoimmune diseases, blood cancers and genetic diseases. Magenta Therapeutics Inc. is headquartered in Cambridge, Mass. “
MarketWise (NASDAQ:MKTW) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $3.25 price target on the stock. According to Zacks, “MarketWise LLC provide multi-brand digital subscription services platform. It offers premium financial research, software, education and tools for self-directed investors. MarketWise LLC, formerly known as Ascendant Digital Acquisition Corp., is based in NEW YORK. “
Melco Resorts & Entertainment (NASDAQ:MLCO) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Melco Resorts & Entertainment Ltd is a developer, owner and operator of casino gaming and entertainment casino resort facilities primarily in Asia. Melco Resorts & Entertainment Ltd, formerly known as Melco Crown Entertainment Limited, is based in Hong Kong. “
MeridianLink (NYSE:MLNK) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $17.00 price target on the stock. According to Zacks, “MeridianLink Inc. is a cloud-based technology company which enables banks, credit unions, mortgage lenders, specialty lending providers and consumer reporting agencies to streamline loan decision making, loan origination, and customer collection workflows. MeridianLink Inc. is based in Costa Mesa, Calif. “
ArcelorMittal (NYSE:MT) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. Zacks Investment Research currently has $32.00 price target on the stock. According to Zacks, “ArcelorMittal’s adjusted earnings and sales for the first quarter of 2022 beat the respective Zacks Consensus Estimate. The company remains focused on reducing costs. It is implementing a $1-billion fixed cost reduction program that is expected to lend support to its bottom line. Footprint optimization should also aid in improving cost optimization. ArcelorMittal’s efforts to reduce debt is also encouraging. It also has a strong liquidity position and remains committed to return value to shareholders. Further, the company is expanding its steel-making capacity. It is also focused on shifting to high-added value products, including automotive steel line. The new generation of advanced high strength steels (AHSS) allow the company to meet customer requirements through a strong technical and product portfolio.”
McEwen Mining (NYSE:MUX) (TSE:MUX) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “U.S. GOLD CORP. is primarily engaged in the precious metal mining business in the continental United States, however, it may also evaluate properties outside the United States. “
Microvast (NASDAQ:MVST) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Microvast Inc. is a technology company. It designs, develops and manufactures lithium-ion battery solutions. Microvast Inc., formerly known as Tuscan Holdings Corp., is headquartered in Houston, TX. “
Myomo (NYSEAMERICAN:MYO) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals. Myomo, Inc. is headquartered in Cambridge,Massachusetts. “
Nitori (OTC:NCLTY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $10.00 target price on the stock. According to Zacks, “Nitori Holdings Co. Ltd. is engaged in the sale of furniture and interior goods. The Company is involved in the sale of furniture and interior goods, the renovation and sale of used houses, as well as the leasing of real estate through consolidated subsidiaries and affiliates. It is also engaged in the logistics business, the advertising business and the insurance agency business. Nitori Holdings Co. Ltd. is based in Tokyo, Japan. “
NGL Energy Partners (NYSE:NGL) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $2.25 target price on the stock. According to Zacks, “NGL Energy Partners LP is a limited partnership operating a vertically-integrated propane business with three operating segments: retail propane; wholesale supply and marketing; and midstream. The Retail Propane segment engages in retail marketing, sale, and distribution of propane, including the sale and lease of propane tanks, equipment, and supplies to residential, agricultural, commercial, and industrial customers through customer service locations. The Wholesale Supply and Marketing segment supplies propane and other natural gas liquids, as well as provides related storage to retailers, wholesalers, and refiners. The Midstream segment involves in the delivery of propane from pipelines or trucks to propane terminals and transfers the propane to third-party transport trucks for delivery to retailers, wholesalers, or other consumers. NGL Energy Partners LP is headquartered in Tulsa, Oklahoma. “
NeoGames (NASDAQ:NGMS) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “NeoGames S.A. is a technology-driven provider of end-to-end iLottery solutions for national and state-regulated lotteries. NeoGames S.A. is based in LUXEMBOURG. “
Niu Technologies (NASDAQ:NIU) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Niu Technologies is a provider of smart urban mobility solutions. It designs, manufactures and sells smart e-scooters. The company’s product portfolio consists of N, M and U with multiple models and specifications for consumer, delivery and sharing markets. Niu Technologies is based in Beijing, China. “
Nikola (NASDAQ:NKLA) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Nikola Corporation manufactures electric vehicles. The company offers battery-electric and hydrogen fuel-cell electric vehicles. It also manufactures semi-trucks and powersports vehicles. Nikola Corporation, formerly known as Vectoiq Acq CP, is based in Phoenix, Arizona. “
Nautilus (NYSE:NLS) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $3.25 target price on the stock. According to Zacks, “Nautilus, Inc. is an iconic industry leader with a rich history and reputation for building the best cardio and strength equipment for home use. Known for its family of brands that included Bowflex, Nautilus, Octane Fitness, Schwinn, and Universal, the company develops, manufacturers and markets branded products that include home gyms, free weight equipment, treadmills, indoor cycling equipment, ellipticals, and fitness accessories. “
Novanta (NASDAQ:NOVT) was upgraded by analysts at William Blair from a market perform rating to an outperform rating.
Kongsberg Gruppen ASA (OTCMKTS:NSKFF) was upgraded by analysts at Pareto Securities from a sell rating to a hold rating.
OFS Capital (NASDAQ:OFS) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $13.00 price target on the stock. According to Zacks, “OFS Capital Corporation is a closed-end, non-diversified management investment company. It is engaged in providing capital to North American middle market companies. Its investment objective is to provide its stockholders with both current income and capital appreciation primarily through debt investments and equity investments in asset classes including senior secured, unitranche, second-lien and mezzanine loans. “
Oncorus (NASDAQ:ONCR) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $1.25 target price on the stock. According to Zacks, “Oncorus Inc. is a clinical stage biopharmaceutical company. It is focused on developing viral immunotherapies to transform outcomes for cancer patients. The company’s product candidate includes ONCR-177, which is in clinical stage. Oncorus Inc. is based in CAMBRIDGE, Mass. “
Offerpad Solutions (NYSE:OPAD) was upgraded by analysts at Zacks Investment Research from a sell rating to a buy rating. The firm currently has $5.25 price target on the stock. According to Zacks, “OfferPad Inc. provide tech-enabled platform for buying and selling residential real estate. OfferPad Inc., formerly known as Supernova Partners Acquisition Company Inc., is based in CHANDLER, Ariz. “
Oportun Financial (NASDAQ:OPRT) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Oportun Financial Corporation is a Community Development Financial Institution providing financial services. It operates primarily in Arizona, California, Florida, Idaho, Illinois, Missouri, Nevada, New Jersey, New Mexico, Texas, Utah and Wisconsin. Oportun Financial Corporation is based in SAN CARLOS, Calif. “
Oatly Group (NASDAQ:OTLY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Oatly Group AB is an oat drink company. Oatly Group AB is headquartered in Malmö, Sweden. “
Otter Tail (NASDAQ:OTTR) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.
Oxford Square Capital (NASDAQ:OXSQ) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.
Oxford Square Capital (NASDAQ:OXSQ) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Oxford Square Capital Corp. is a business development company principally investing in syndicated bank loans and debt and equity tranches of CLO vehicles. Oxford Square Capital Corp., formerly known as TICC Capital Corp., is based in Greenwich, United States. “
Oyster Point Pharma (NASDAQ:OYST) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Oyster Point Pharma Inc. is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of pharmaceutical therapies to treat ocular surface diseases. The company’s lead product candidate, OC-01, is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. Oyster Point Pharma Inc. is based in Princeton, New Jersey. “
Flutter Entertainment (OTCMKTS:PDYPY) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Flutter Entertainment PLC is involved in bookmaking business. Its brands portfolio consists of Betfair, Paddy Power, Sportsbet, TVG and FanDuel. Flutter Entertainment PLC, formerly known as Paddy Power Betfair plc, is based in DUBLIN, Ireland. “
PGT Innovations (NYSE:PGTI) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “PGT INDUSTRIES pioneered the U.S. impact-resistant window and door industry and today is the nation’s leading manufacturer and supplier of residential impact-resistant windows and doors. PGT is also one of the largest window and door manufacturers in the United States. The company’s total line of custom windows and doors is now available throughout the eastern United States, the Gulf Coast and in a growing international market, which includes the Caribbean, South America and Australia. PGT’s product line includes PGT Aluminum and Vinyl Windows and Doors; WinGuard Impact-Resistant Windows and Doors; PGT Architectural Systems; and Eze-Breeze Sliding Panels. PGT Industries is a wholly owned subsidiary of PGT, Inc. “
Park-Ohio (NASDAQ:PKOH) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Park Ohio Holdings Corp. operates through two segments, Manufactured Products and Logistics, which serve a wide variety of industrial markets. Manufactured Products designs and manufactures a broad range of high quality products engineered for specific customer applications. The principal customers of Manufactured Products are original equipment manufacturers and end-users in the automotive, railroad, truck and aerospace industries. Logistics is a leading national supplier of fasteners (e.g., nuts, bolts and screws) and other industrial products. “
Planet Fitness (NYSE:PLNT) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. The firm currently has $90.00 target price on the stock.
The Pennant Group (NASDAQ:PNTG) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “The Pennant Group Inc. through subsidiaries offers home health, hospice and senior living services. It operates primarily in Arizona, California, Colorado, Idaho, Iowa, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. The Pennant Group Inc. is based in Eagle, United States. “
PROCEPT BioRobotics (NASDAQ:PRCT) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. It focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics Corporation is based in REDWOOD CITY, Calif. “
Peloton Interactive (NASDAQ:PTON) was upgraded by analysts at JMP Securities from a market perform rating to an outperform rating. They currently have $25.00 target price on the stock.
PetroChina (NYSE:PTR) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.
Prudential (NYSE:PUK) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “PRUDENTIAL PLC provides retail financial products and services and fund management to many millions of customers worldwide. Their commitment to the shareholders who own Prudential is to maximise the value over time of their investment. They do this by investing for the long term to develop and bring out the best in their people and their businesses to produce superior products and services, and hence superior financial returns. Their aim is to deliver top quartile performance among their international peer group in terms of total shareholder returns. “
PowerFleet (NASDAQ:PWFL) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “PowerFleet Inc. is a provider of subscription-based wireless IoT and M2M solutions for securing, controlling, tracking and managing enterprise assets such as industrial trucks, tractor trailers, containers, cargo and vehicles and truck fleets. Its brand consists of PowerFleet, Pointer and Cellocator. PowerFleet Inc., formerly known as I.D. Systems, is headquartered in Woodcliff Lake, New Jersey. “
Poxel (OTCMKTS:PXXLF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Poxel SA is a biopharmaceutical company. It offers drugs for metabolic diseases such as diabetes and related metabolic disorders. The company’s product pipeline consists of Imeglimin, PXL770 and PXL007 which are in clinical trial stage. Poxel SA is headquartered in Lyon, France. “
Ritchie Bros. Auctioneers (NYSE:RBA) (TSE:RBA) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Ritchie Bros. Auctioneers conduct unreserved public auctions every year at locations throughout North and Central America, Europe, Asia, Australia, Africa and the Middle East. The company is known for their innovative auction methods, attention to detail and their total commitment to the unreserved auction. The confidence this gives their customers has enabled Ritchie Bros. to become one of the largest industrial auctioneer in the world. “
Construction Partners (NASDAQ:ROAD) was upgraded by analysts at Raymond James from an outperform rating to a strong-buy rating. The firm currently has $25.00 target price on the stock, down from their previous target price of $30.00.
Rapid7 (NASDAQ:RPD) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Rapid7, Inc. offers security data and analytics solutions. The Company provides solutions which consist of threat exposure management, incident detection and response solutions as well as security advisory services. Rapid7, Inc. is based in Boston, United States. “
Prometheus Biosciences (NASDAQ:RXDX) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Prometheus Biosciences Inc. is a biotechnology company. It involved in the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of inflammatory bowel disease. Prometheus Biosciences Inc. is based in SAN DIEGO. “
Rackspace Technology (NASDAQ:RXT) was upgraded by analysts at Raymond James from a market perform rating to an outperform rating. The firm currently has $12.00 price target on the stock.
SailPoint Technologies (NYSE:SAIL) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $70.00 price target on the stock. According to Zacks, “SailPoint Technologies Holdings, Inc. is a provider of enterprise identity governance solutions. The Company’s products and services include Open Identity Platform, Cloud-based Identity Governance, On-premises Identity Governance, Data Access Governance, Identity Analytics, Healthcare Identity Solutions and Federal Identity Solutions. SailPoint Technologies Holdings, Inc. is based in Austin, United States. “
comScore (NASDAQ:SCOR) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.
Shoe Carnival (NASDAQ:SCVL) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. The firm currently has $35.00 price target on the stock. According to Zacks, “Shoe Carnival, Inc. is one of the nation’s largest family footwear retailers, offering a broad assortment of moderately priced dress, casual and athletic footwear for men, women and children with emphasis on national and regional name brands. The Company operates 404 stores in 33 states and Puerto Rico, and offers online shopping at www.shoecarnival.com. Headquartered in Evansville, IN, Shoe Carnival trades on the NASDAQ Stock Market LLC under the symbol SCVL. Shoe Carnival is committed to earning the highest level of respect of their customers, shareholders, communities and employees. “
Vivid Seats (NASDAQ:SEAT) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Vivid Seats Inc. provides marketplace which utilizes its technology platform to connect buyers with ticket sellers. Vivid Seats Inc., formerly known as Horizon Acquisition Corporation, is based in CHICAGO. “
Selecta Biosciences (NASDAQ:SELB) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $0.75 target price on the stock. According to Zacks, “Selecta Biosciences, Inc. is a biopharmaceutical company which develops targeted immunotherapies and vaccines. Its product pipelineincludes gene therapy, food allergy, malaria; SEL-212, which is a therapeutic enzyme indicated for refractory gout; SEL-070, which is indicated for smoking cessation and relapse prevention; SEL-701, which is indicated for the treatment of human papillomavirus associated cancer and SEL-212 consists of SVP-Rapamycin co-administered with pegsiticase, its pegylated uricase. Selecta Biosciences, Inc. is based in Watertown, United States. “
Spectris (OTCMKTS:SEPJY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Spectris Plc manufactures, develops and supplies industrial automation equipment. The company comprises Materials Analysis segment, Test & Measurement segment, In-Line Instrumentation segment and Industrial Controls segment. The Materials Analysis segment provides products to determine structure, composition, quantity and quality of particles and materials. The Test and Measurement segment supplies test, measurement and analysis equipment and software for product design, manufacturing control and environmental monitoring systems. The In-line Instrumentation segment provides process analytical measurement, asset monitoring and on-line controls for both primary processing and the converting industries. The Industrial Controls segment provides products and solutions which monitor, control, inform, track and trace during the production process. Spectris Plc is headquartered in Egham, the United Kingdom. “
Sera Prognostics (NASDAQ:SERA) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Sera Prognostics Inc. is a women’s health diagnostics company. It focused on improving maternal and neonatal health by providing pregnancy biomarker information to doctors and patients. Sera Prognostics Inc. is based in SALT LAKE CITY. “
SES (OTCMKTS:SGBAF) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $9.75 price target on the stock. According to Zacks, “SES S.A. provides satellite broadband communications services. It offers video services, such as broadcasting, content distribution and occasional use and full-time video contribution services. The company also provides enterprise services, including enterprise broadband, infrastructure as a service, bandwidth, and customized connectivity and tailored services. SES S.A. is based in Luxembourg. “
Shionogi & Co., Ltd. (OTCMKTS:SGIOY) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Shionogi & Co., Ltd. engages in the research, development, manufacture and distribution of pharmaceuticals, diagnostic reagents, and medical devices. Its primary products Tivicay for HIV treatment; Mulpleta for the treatment of thrombocytopenia; Xofluza, an influenza drug; Symproic for opioid-induced constipation treatment and Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment. Shionogi & Co., Ltd. is based in Osaka, Japan. “
Skillsoft (NASDAQ:SKIL) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Skillsoft Corp. delivers digital learning, training and talent solutions. The company democratizes learning through an intelligent learning experience and a customized, learner-centric approach to skills development with resources for Leadership Development, Business Skills, Technology and Developer, Digital Transformation and Compliance. Skillsoft Corp., formerly known as Churchill Capital Corp II, is based in NEW YORK. “
SkyWater Technology (NASDAQ:SKYT) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “SkyWater Technology is a pure play semiconductor foundry and is a supplier which specializes in custom technology development services, volume manufacturing and advanced packaging capabilities. SkyWater Technology is based in BLOOMINGTON, Minn. “
Snap One (NASDAQ:SNPO) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Snap One Holdings Corp. is a provider of smart living products, services and software to professional integrators. Snap One Holdings Corp. is based in CHARLOTTE, N.C. “
Electrameccanica Vehicles (NASDAQ:SOLO) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $1.75 price target on the stock. According to Zacks, “Electrameccanica Vehicles Corp. is engaged in the planning, development and manufacturing of single person electric vehicles. Electrameccanica Vehicles Corp. is headquartered in Vancouver, Canada. “
SP Plus (NASDAQ:SP) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $32.00 price target on the stock. According to Zacks, “SP Plus Corporation provides professional parking, ground transportation, facility maintenance, security and event logistics services to property owners and managers in all markets of the real estate industry. The Company also provides a range of ancillary services, such as airport shuttle operations, taxi and livery dispatch services and municipal meter revenue collection and enforcement services. Its clients include owners of office building complexes, shopping centers, sports complexes, hotels, hospitals, and various airports. SP Plus Corporation, formerly known as Standard Parking Corporation, is based in United States. “
Spirax-Sarco Engineering (OTCMKTS:SPXSF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Spirax-Sarco Engineering plc is a multi-national engineering group. The company’s business segment consists of Spirax Sarco for steam specialties and Watson-Marlow for niche peristaltic pumps and associated fluid path technologies. Spirax-Sarco Engineering plc is headquartered in Cheltenham, the United Kingdom. “
Scholar Rock (NASDAQ:SRRK) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $6.50 target price on the stock. According to Zacks, “Scholar Rock Holding Corporation is a biopharmaceutical company. It focused on the discovery and development of medicines for treatment of serious diseases. The company’s product candidate includes SRK-015 and BMP6 which is in pre-clinical stage. Scholar Rock Holding Corporation is based in Cambridge, United States. “
Sumo Logic (NASDAQ:SUMO) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Sumo Logic Inc. provides software solutions. The company’s Sumo Logic Continuous Intelligence Platform(TM) automates the collection, ingestion and analysis of application, infrastructure, security, and IoT data to derive actionable insights. Sumo Logic Inc. is based in CA, United States. “
Supernus Pharmaceuticals (NASDAQ:SUPN) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland. “
Smith & Wesson Brands (NASDAQ:SWBI) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Smith & Wesson Brands, Inc. designs, manufactures and sells firearms. The Company offers pistols, revolvers, rifles, handcuffs and other related products and accessories under the Smith & Wesson, M&P, Performance Center, Thompson/Center Arms and Gemtech brands. Smith & Wesson Brands, Inc., formerly known as American Outdoor Brands Corporation, is based in Springfield, Massachusetts. “
Standex International (NYSE:SXI) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $108.00 price target on the stock. According to Zacks, “Standex International Corp. is a diversified manufacturer producing and marketing a wide variety of useful, quality products. The company enjoys a broad and well-balanced earnings base by virtue of its strong market position in selected areas of operation. (PRESS RELEASE) “
TransAct Technologies (NASDAQ:TACT) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “TransAct Technologies, Incorporated, designs, develops, manufactures and markets transaction-based printers and related products under the ITHACA and MAGNETEC and TRANSACT.COM brand names. The company focuses on five vertical markets: point-of-sale(POS), gaming and lottery, financial services, kiosk and Internet. The company’s printers are trusted world-wide to provide crisp, clean transaction records from receipts, tickets and coupons, register journal and other documents. “
TriCo Bancshares (NASDAQ:TCBK) was upgraded by analysts at Stephens from an equal weight rating to an overweight rating. They currently have $48.00 target price on the stock, up from their previous target price of $46.00.
TScan Therapeutics (NASDAQ:TCRX) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $1.75 target price on the stock. According to Zacks, “TScan Therapeutics Inc. is a biopharmaceutical company. It focused on the development of T-cell receptor engineered T cell therapies for the treatment of patients with cancer. The company’s lead product pipeline consist TSC-100 and TSC-101. TScan Therapeutics Inc. is based in WALTHAM, Mass. “
Teleflex (NYSE:TFX) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.
Thryv (NASDAQ:THRY) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. Zacks Investment Research currently has $28.00 target price on the stock. According to Zacks, “Thryv Holdings Inc. provides small-to-medium sized businesses with print and digital marketing solutions and Software as a Service end-to-end customer experience tools. Thryv Holdings Inc. is based in Dallas. “
Interface (NASDAQ:TILE) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $14.00 price target on the stock. According to Zacks, “Interface, Inc. is the world’s largest manufacturer of modular carpet, which it markets under the Interface and FLOR brands. The Company is committed to the goal of sustainability and doing business in ways that minimize the impact on the environment while enhancing shareholder value. Interface is the world’s largest manufacturer of modular carpet. Their heritage began with the invention of the first carpet tile approximately 50 years ago by a Dutch company called Heuga, now part of InterfaceFLOR. From that spark of invention, they have continued to innovate, giving the award-winning modular carpet design, pioneering environmental practices and ground-breaking manufacturing technology. Their products are designed for a wide range of commercial environments including corporate, healthcare, education, retail, hospitality and government. We continue to lead the industry in environmental achievement and the exploration of environmentally efficient products and processes. “
TELUS International (Cda) (NYSE:TIXT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $24.00 target price on the stock. According to Zacks, “TELUS International designs, builds and delivers next-generation digital solutions for global and disruptive brands. The company provides integrated solutions and capabilities span digital strategy, innovation, consulting and design, digital transformation and IT lifecycle solutions, data annotation and intelligent automation, and omnichannel CX solutions which include content moderation, trust and safety solutions and other managed solutions. TELUS International is based in VANCOUVER, British Columbia. “
Receive News & Ratings for adidas AG Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for adidas AG and related companies with MarketBeat.com’s FREE daily email newsletter.
link
